MSD

Pembrolizumab

Biodrugs/ Drugs
Cancer
Pembrolizumab Versus Placebo as Adjuvant Therapy in High-risk Locally Advanced Cutaneous Squamous Cell Carcinoma
3Phase III in Spain, 2Phase II, 1Phase I